Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial
In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings
Other ASCO Plenary Papers: Long Awaited Chemotherapy Results
Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More
Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session
NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation
Trending Stories
- Cancer clinical trials shouldn’t discriminate—but they do
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?
- In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on schedule
Helene knocks out Baxter facility, creating shortage of IV fluids - ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted - Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”